News

Bristol-Myers Squibb Company (NYSE:BMY) is one of the top low volatility healthcare stocks to buy now. On July 24, Goldman ...
Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...
Coming up: a key tariffs deadline, the Fed’s interest-rate decision, the July jobs report, fresh inflation data, and earnings from companies including Microsoft, Meta, Apple and Amazon.
First-line treatment with the monoclonal antibody is associated with more patients achieving robust clinical response at 3 months vs standard of care, but by 6 months no advantage remained.
This will be the busiest earnings week of the second quarter, with about 150 S&P 500 companies reporting. Investors will also ...
The stock market is at record highs as investors brace for what's expected to be the busiest week of the summer on Wall ...
Also on Trump’s mind is the Federal Reserve. Its chair Jay Powell will on Wednesday unveil the US central bank’s decision on interest rates. The uncomfortable relationship between the president and ...
Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...